Shopping Cart
- Remove All
- Your shopping cart is currently empty
Samuraciclib (CT7001) hydrochloride hydrate is a potent, selective, ATP-competitive, orally active inhibitor of CDK7 (IC50: 41 nM). It inhibits the growth of breast cancer cell lines (GI50: 0.2-0.3 μM) and exhibits potent antitumor effects.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $987 | 10-14 weeks | |
50 mg | $1,320 | 10-14 weeks | |
100 mg | $1,990 | 10-14 weeks |
Description | Samuraciclib (CT7001) hydrochloride hydrate is a potent, selective, ATP-competitive, orally active inhibitor of CDK7 (IC50: 41 nM). It inhibits the growth of breast cancer cell lines (GI50: 0.2-0.3 μM) and exhibits potent antitumor effects. |
Targets&IC50 | CDK6:31 μM, CDK1:1.8 μM, CDK6:34 μM, CDK7-CyclinH-MAT1:41 nM, CDK5:9.4 μM, CDK4:49 μM, CDK7:41 nM, CDK2:578 nM, CDK9:1.2 μM, CDK2/cyclin E1:578 nM |
Molecular Weight | 521.7 |
Formula | C22H35ClN6O3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.